Impact of Vitiligo on Life Quality of Patients: Assessment of Currently Available Tools.

Ting-Ting Yang Chien-Hung LeeCheng-Che E Lan

Published in: International journal of environmental research and public health (2022)

There exist discrepancies in the outcomes identifying significant disease burden of vitiligo using DLQI and SF-36, making the current DLQI cutoff score (>10) for identifying significantly affected QoL inappropriate for these patients.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
type diabetes
patient reported outcomes
metabolic syndrome